sulforaphane has been researched along with Multiple Myeloma in 2 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Multiple myeloma is a fatal disease characterized by clonal proliferation of plasma cells in the bone marrow." | 5.37 | Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma. ( Anderson, KC; Blotta, S; Cervi, D; Cholujova, D; Daley, JF; Delmore, J; Hideshima, T; Jakubikova, J; Kim, K; Klippel, S; Leiba, M; McMillin, DW; Mitsiades, CS; Nahar, S; Negri, J; Ooi, M; Richardson, PG; Sedlak, J, 2011) |
| "Multiple myeloma is a fatal disease characterized by clonal proliferation of plasma cells in the bone marrow." | 1.37 | Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma. ( Anderson, KC; Blotta, S; Cervi, D; Cholujova, D; Daley, JF; Delmore, J; Hideshima, T; Jakubikova, J; Kim, K; Klippel, S; Leiba, M; McMillin, DW; Mitsiades, CS; Nahar, S; Negri, J; Ooi, M; Richardson, PG; Sedlak, J, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jakubikova, J | 1 |
| Cervi, D | 1 |
| Ooi, M | 1 |
| Kim, K | 1 |
| Nahar, S | 1 |
| Klippel, S | 1 |
| Cholujova, D | 1 |
| Leiba, M | 1 |
| Daley, JF | 1 |
| Delmore, J | 1 |
| Negri, J | 1 |
| Blotta, S | 1 |
| McMillin, DW | 1 |
| Hideshima, T | 1 |
| Richardson, PG | 1 |
| Sedlak, J | 1 |
| Anderson, KC | 1 |
| Mitsiades, CS | 1 |
| Doudican, NA | 1 |
| Wen, SY | 1 |
| Mazumder, A | 1 |
| Orlow, SJ | 1 |
2 other studies available for sulforaphane and Multiple Myeloma
| Article | Year |
|---|---|
Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line; Cell Proliferation; Cell Survival; | 2011 |
Sulforaphane synergistically enhances the cytotoxicity of arsenic trioxide in multiple myeloma cells via stress-mediated pathways.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Caspase 3; Caspases, Initiator; Cell | 2012 |